Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Acromegaly × pasireotide × Clear all

Phase

Phase 3 2 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 4 Carcinoid Tumor 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Adenoma, Islet Cell 1 Adenocarcinoma 1 Acromegaly 1

Interventions

pasireotide 1 lanreotide 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00446082 2020-12-21

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Novartis

Phase 1 Completed

Acromegaly, Carcinoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡